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A B S T R A C T
Recent developments in CRISPR technologies have opened new possibilities for improving genome editing tools
dedicated to the Clostridium genus. In this study we adapted a two-plasmid tool based on this technology to
enable scarless modiﬁcation of the genome of two reference strains of Clostridium beijerinckii producing an
Acetone/Butanol/Ethanol (ABE) or an Isopropanol/Butanol/Ethanol (IBE) mix of solvents. In the NCIMB 8052
ABE-producing strain, inactivation of the SpoIIE sporulation factor encoding gene resulted in sporulation-deﬁ-
cient mutants, and this phenotype was reverted by complementing the mutant strain with a functional spoIIE
gene. Furthermore, the fungal cellulase-encoding celA gene was inserted into the C. beijerinckii NCIMB 8052
chromosome, resulting in mutants with endoglucanase activity. A similar two-plasmid approach was next used to
edit the genome of the natural IBE-producing strain C. beijerinckii DSM 6423, which has never been genetically
engineered before. Firstly, the catB gene conferring thiamphenicol resistance was deleted to make this strain
compatible with our dual-plasmid editing system. As a proof of concept, our dual-plasmid system was then used
in C. beijerinckii DSM 6423 ΔcatB to remove the endogenous pNF2 plasmid, which led to a sharp increase of
transformation eﬃciencies.
1. Introduction
Solventogenic Clostridia are mesophilic, rod shaped gram positive,
anaerobic and sporogenic bacteria belonging to the Firmicutes phylum.
Model species such as Clostridium acetobutylicum and Clostridium bei-
jerinckii are able to produce a wide range of valuable chemicals among
which acetone/isopropanol, butanol and ethanol during the A/IBE
fermentation [1–5]. Moreover, Clostridium species have been reported
to produce other chemicals such as acetoin, 2,3-butanediol [2,6], or
1,3-propanediol [7–9]. However, the A/IBE fermentations suﬀer from
the low end-products ﬁnal concentrations mainly related to their toxi-
city [10].
Over the last decades, many eﬀorts were made to improve the sol-
vent tolerance and productivity of solventogenic Clostridia by genetic
engineering. Forward genetics (i.e. random mutagenesis) have been
mostly used to study molecular mechanisms in Clostridia [11,12], be-
cause targeted mutagenesis has long been impeded by the lack of eﬃ-
cient genetic tools for the Clostridium genus. Since the adaptation of the
TargeTron technology [13] to the Clostridia genus in 2007 and the
creation of a genetic tool called ClosTron [14,15]), targeted approaches
have been greatly facilitated. This technology allows gene disruption
through the precise insertion of a mobile group II intron into the
genome. However, polar eﬀects on ﬂanking genes have been reported,
making the subsequent analysis of mutant phenotypes diﬃcult [16].
Moreover, considering that this method does not enable large genetic
insertions, other tools were created to alleviate these bottlenecks. In
particular, strategies using counter-selection markers have been de-
veloped to select rare allelic exchange events [17–19]. In 2013, Al-
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Hinai et al. described a markerless genome editing strategy using the
MazF toxin from Escherichia coli as a counter selection marker [17]. The
methodology enabled the deletion of several genes and the insertion of
a 3.6 kb DNA fragment leaving a FRT scar in the modiﬁed chromosome.
Ehsaan et al. developed the ACE system (Allele Coupled Exchange)
using the pyrE gene, encoding the pyrimidine biosynthesis enzyme
“orotate phosphoribosyltransferase”, as a positive and negative selec-
tion marker [18,20]. However, these methods are time consuming as
they require several selection and subculturing steps. The cells in which
the plasmid has been integrated into the genome via a single crossover
event are selected and then subcultured in selective media to further
allow the allelic exchange. This lengthens the engineering process and
favors the occurrence of spontaneous mutations.
CRISPR-Cas9 technology for genetic modiﬁcation of eukaryotic and
prokaryotic cells provides an alternative to these genome editing
methods [21]. Recently, several publications reported the use of
CRISPR-Cas9 tools for scarless genome editing in Clostridium celluloly-
ticum [22], C. acetobutylicum [23] and C. beijerinckii [23–26]. Most
groups reported diﬃculties when the native Cas9 nuclease from S.
pyogenes was constitutively expressed. Indeed, the double strand break
(DSB) generated by Cas9 is reported to be lethal because of the absence
of non-homologous end-joining (NHEJ) mechanisms in Clostridia
[22,27]. Therefore, the Cas9 nuclease was often replaced by a Cas9
nickase [23,25] in which the RuvC domain was mutated (D10A) [28].
This methodology enabled the insertion of DNA fragments up to 1.7 kb
after serial transfers [22]. Alternatively, Wang et al. [24] overcame the
DSB lethality by placing the cas9 gene under the control of a lactose
inducible promoter [29] enabling deletions, insertions or single-nu-
cleotide modiﬁcations (SNM) within the genome of C. beijerinckii. All
the systems described above are based on a “single vector strategy”.
Such strategies are however limited due to the length of the cas9 gene
(4.1 kb), which restricts the cargo capacity of the transformation vec-
tors and therefore limits the size of potential genome insertions.
Approaches using two separate plasmids for the sequential in-
troduction of the cas9 gene and the gRNA sequence into a targeted
strain have been recently described in the solventogenic C. acet-
obutylicum [30] and in the acetogen C. authoethanogenum [31]. In the
case of C. acetobutylicum, the system enabled precise genome editing
with an eﬃciency of 100%. Indeed, the system enabled several mod-
iﬁcations ranging from a single base pair substitution to the genomic
insertion of a 3.6 kb DNA fragment. In the case of C. autoethanogenum,
the system enabled a partial deletion of an alcohol dehydrogenase gene
and the deletion of a 2,3-butanediol dehydrogenase gene (1 kb) with an
eﬃciency of 50%. Although being powerful, the two-plasmid editing
strategy requires two functional selection markers, which might not
always be available for some strains.
In this study, we adapted our recently-described dual-plasmid
CRISPR-Cas9 genetic tool [30] to edit C. beijerinckii strains. In the ABE
model strain C. beijerinckii NCIMB 8052, the cas9 gene and the gRNA
expression cassette were placed on two distinct plasmids. Both cas9 and
gRNA were placed under the control of a xylose inducible promoter
[32] to enable a tight control of nuclease activity. The homologous DNA
repair template, required for allelic exchange, was placed on the same
plasmid as the gRNA expression cassette. The lethal eﬀect of DSB was
taken as a strong asset to use the CRISPR system as a counter-selection
against unedited cells. This system enabled the scarless deletion of
2.379 kb within the spoIIE gene (cbei_0097) as well as the insertion of
the celA gene from Neocallimastix patriciarum in C. beijerinckii NCIMB
Table 1
Strains and plasmids used in this study.
Strains and plasmids Relevant information Reference or source
Clostridia
Clostridium beijerinckii NCIMB 8052 ABE producer, sensitive to erythromycin (25–50 µg/mL) and spectinomycin (650 µg/mL) [46]
Clostridium beijerinckii DSM 6423 IBE producer, adh gene, sensitive to erythromycin (25–50 µg/mL), resistant to thiamphenicol (15 µg/mL) [3]
Clostridium diﬃcile str. 630 Gene xylR and promoter of the gene xylB [29]
Other microbial strains
E. coli XL1-blue endA1 gyrA96(nalR) thi-1 recA1 relA1 lac glnV44 F'[::Tn10 proAB+ lacIq Δ(lacZ)M15] hsdR17(rK- mK+ ) Agilent
E. coli NEB 10-beta Δ(ara-leu) 7697 araD139 fhuA ΔlacX74 galK16 galE15 e14-ϕ80dlacZΔM15 recA1 relA1 endA1 nupG rpsL (StrR) rph
spoT1 Δ(mrr-hsdRMS-mcrBC)
NEB
E. coli INV110 F' {traΔ36 proAB lacIq lacΔM15} rpsL (StrR) thr leu endA thi-1 lacY galK galT ara tonA tsx dam dcm supE44 Δ(lac-
proAB) Δ(mcrCmrr)102::Tn10(TetR)
Invitrogen
S. cerevisiae W303 MATa/MATα {leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15} [phi+ ] ATCC 200060
C. beijerinckii NCIMB 8052 genome editing plasmids
pMTL500E ApR ; EmR; colE1 ; pAMβ1 [35]
pSEC500E ApR ; EmR; colE1 ; pAMβ1 ; 2µ ; URA3 This study
pYC100S SpR; colE1; pCB102; 2µ ; URA3 This study
pWUR100S (pS) SpR; colE1; pCB102 This study
pE_X_cas9 pSEC500E derivative with cas9 (inducible xylB promoter) insertion This study
pS_XRKR pWUR100S derivative with KanR; chimera reprogrammable gRNA (inducible xylB promoter) and MCS This study
pS_XR_celA_S1 pSXRKR derivative with cassette “celA” and gRNA celA_S1 (PAM sequence located 36 bp downstream of the hbd gene
(cbei_0325) stop codon) insertion
This study
pS_XRThlPcelA_S1 pS_XR_celA_S1 derivative with the thl promoter from cbei_0411 This study
pS_XR_ΔspoIIE_S1 pSXRKR derivative with cassette “ΔSpoIIE” and gRNA spoIIE_S1 (PAM located 571 bp downstream the start codon of
spoIIE) insertion
This study
pWUR3 pMTL500E derivative with celA (constitutive promoter eglA and its signal peptide) insertion [41]
SpoIIE complementation plasmid
pSpoIIE pWUR100S derivative with the spoIIE (cbei_0097) This study
C. beijerinckii DSM 6423 genome editing plasmids
pFW01 EmR; colE1; pCB102 Wasels et al. (2017)
pCas9ind pFW01 derivative with cas9 (inducible Pcm-tetO2/1 promoter) and tetR (miniPthl promoter) insertions Wasels et al. (2017)
pEC750C TmR; colE1; pIP404 Wasels et al. (2017)
pCas9ind-ΔcatB_S1 pCas9ind derivative with cassette “ΔcatB” and gRNA catB_S1 (PAM sequence located 76 bp upstream of the catB gene
(CIBE_3859) stop codon (inducible Pcm-2tetO1 promoter)) insertion
This study
pGRNA-pNF2_S1 pEC750C derivative with gRNA pNF2_S1 (PAM sequence located 285 bp downstream of the CIBE_p20002 gene start/
stop codon (inducible Pcm-2tetO1 promoter)) insertion
This study
Ap, ampicillin; Em, erythromycin; Sp, spectinomycin; Tm, thiamphenicol; Kan, kanamycin; Tet, tetracycline.
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8052 with 100% and 75% eﬃciency, respectively.
The applicability of this two-plasmid approach was also investigated
in the IBE producing C. beijerinckii DSM 6423 strain, for which suc-
cessful genetic modiﬁcation have never been reported so far. Being only
able to use the erythromycin resistance gene as a selection marker, a
preliminary strategy involving a single-plasmid CRISPR-Cas9 tool was
undertaken to inactivate the CIBE_3859 gene (catB), encoding a puta-
tive amphenicol acetyltransferase. The ΔcatB mutant was sensitive to
thiamphenicol and therefore compatible with a two-plasmid editing
approach, which was subsequently used to delete the endogenous pNF2
plasmid as a proof of concept. Interestingly, the removal of this mobile
genetic element resulted in a drastically increased transformation eﬃ-
ciency, paving the way to further genome editing of this natural iso-
propanol producer.
2. Materials and methods
2.1. Strains and culture condition
Relevant characteristics of the bacterial strains and plasmids used in
this study are listed in Table 1. C. beijerinckii NCIMB 8052 and DSM
6423 are laboratory strains. The spoIIE mutant was stored as vegetative
cells in mCGM with 20% glycerol at −80 °C. All the other strains were
kept as spore suspension. Except for fermentation assays, liquid cultures
of C. beijerinckii NCIMB 8052 and related mutants were grown in mCGM
containing per liter: yeast extract, 5 g; KH2PO4, 0.75 g; K2HPO4, 0.75 g;
asparagine·H2O, 2 g; (NH4)2SO4, 2 g; cysteine, 0.5 g; MgSO4·7 H2O,
0.4 g; MnSO4·H2O, 0.01 g; FeSO4·7 H2O, 0.01 g; glucose, 10 g. These
microorganisms were grown and selected on mCGM agar containing
per liter: yeast extract, 1 g; tryptone, 2 g; KH2PO4, 0.5 g; K2HPO4, 1 g;
(NH4)2SO4, 2 g, MgSO4·7 H2O, 0.1 g; MnSO4·H2O, 0.01 g; FeSO4·7 H2O,
0.015 g; CaCl2, 0.01 g; CoCl2, 0.002 g; CaCl2, 0.002 g; glucose, 50 g and
agar 12 g. C. beijerinckii DSM 6423 and related mutants were cultivated
in liquid 2YTG (per liter: tryptone, 16 g; yeast extract, 10 g; NaCl, 5 g;
glucose, 20 g, pH 5.2) and grown on solid 2YTG (same as above, with
neutral pH, 15 g/L agar and 5 g/L glucose). Clostridium mutants were
selected in culture medium containing 50 µg/mL of erythromycin
(Duchefa), 650 µg/mL spectinomycin (Duchefa) and/or 15 µg/mL
thiamphenicol (Sigma-Aldrich), as needed. Liquid media were made
anaerobic by ﬂushing with nitrogen gas or by incubation for at least 4 h
in an anaerobic chamber. Cultivation was performed at 37 °C, without
shaking, and anaerobically in (i) an anaerobic chamber or (ii) in glass
serum vials as described above. E. coli and S. cerevisiae strains were
stored as vegetative cells in 15% glycerol solution at−80 °C. E. coli was
grown on LB medium, supplemented with 100 µg/mL of ampicillin
(Duchefa), 100 µg/mL spectinomycin (Duchefa), 25 µg/mL chlor-
amphenicol (Sigma-Aldrich) and/or 500 µg/mL erythromycin
(Duchefa).
2.2. Plasmid construction and transformation
Except where noted, plasmids and DNA templates used for C. bei-
jerinckii NCIMB 8052 CRISPR system were generated as yeast/E. coli/
Clostridium shuttle vector in the yeast S. cerevisiae by homologous re-
combination as described previously [34]. Yeasts were transformed by
the lithium acetate method [35]. Competent cells were transformed
with linear plasmids and insert(s) produced by PCR. Primers are listed
in supplementary ﬁle S1. Each primer contained a 30 bp 5′-tail speciﬁc
to another DNA fragment to allow homologous recombination. Final
yeast/E. coli/Clostridium shuttle vectors obtained from yeast were di-
gested by AvrII and self-ligated using the T4-DNA ligase (NEB) to evict
the yeast replication origin (2microns) and selection marker (URA3
gene).
The SpoIIE complementation plasmid was constructed using the
Circular Polymerase Extension Cloning [36]. The pS shuttle vector was
digested by SphI and XhoI enzymes for linearization and the insert was
ampliﬁed by PCR on genomic DNA from C. beijerinckii NCIMB 8052
using the primers Cbei0097prom_F and Cbei0097_R.
The plasmid pS_XR_celA_S1 was constructed (with the promoter of
the thl gene, cbei_3630, driving expression of celA) via homologous
recombination in S. cerevisiae using the primers listed in supplementary
ﬁle S1. Unfortunately, non-silent mutations were found in the celA
gene. In the meantime, transcriptome analysis [37] showed that an-
other copy of the thl gene, cbei_0411 was more expressed and thus its
promoter would be a stronger promoter than cbei_3630 and a better
choice. Therefore, to simultaneously address both matters, a BsaI/XcmI
fragment encompassing the relevant regions was replaced with an ac-
cordingly designed synthetic BsaI/XcmI fragment (Genscript). The re-
sulting vector, pS_XRThlPcelA_S1, was sequence-veriﬁed and uses the
promoter of the thl gene (cbei_0411) to drive the expression of the celA
gene.
Plasmids were introduced in C. beijerinckii NCIMB 8052 and related
recombinant strains prepared according to the protocol described pre-
viously [38].
To construct pCas9ind-ΔcatB_S1, a DNA cassette containing the
ΔcatB template DNA as well as the gRNA targeting the C. beijerinckii
DSM 6423 catB locus (anhydrotetracycline inducible promoter) was
synthesized by Euroﬁn Genomics and cloned in the pEX-A258 com-
mercial vector. This cassette was ampliﬁed by PCR (ΔcatB_fwd and
ΔcatB_rev primers) and cloned at the XhoI restriction site in pCas9ind
[30].
To construct pGRNA-pNF2, a gRNA expression cassette composed of
the Pcm-2tetO1 promoter [39] and a 20-nt guiding sequence targeting
pNF2 fused with the chimeric gRNA sequence [28], pNF2-gRNA, was
synthesized (Euroﬁns Genomics, sequence available in supplementary
ﬁle S1), and cloned into the SacI-digested pEC750C.
Prior to electroporation, plasmids were transformed in a dam−
dcm− E. coli strain (INV110, Invitrogen). Dam− Dcm− DNA was then
used to transform C. beijerinckii DSM 6423 as described previously [40],
with a few modiﬁcations outlined thereafter. 2YTG 20 g/L glucose was
used for liquid cultures. Mid-exponential phase (OD600= 0.6–0.8) cells
were used and 5–20 µg DNA was electroporated with a single pulse
(100Ω, 25 µF, 1,4 kV) in 2mm-gap cuvettes.
2.3. Reprogramming the gRNA protospacer in pS_XRKR
The CRISPR-Cas9 target sequences were selected after a manual
search in the target region for a 25 bp spacer sequence ﬂanked in its 3′
end by a 5′-NGG-3′ motif named protospacer adjacent motif (PAM). The
spacer was designed by the annealing of two primers; (i) the primer
“Target_Forw” consisting in the spacer sequence to which the motif “5′-
GAGG-3′” was added at its 5′ end and (ii) the primer “Target_Rev”
consisting in the reverse complement of the spacer sequence to which
the motif “5′-AAAC-3′” was added at its 5′ end. Both primers were
mixed (1 µM each), heated at 95 °C for 10min and cooled down at room
temperature. The primer dimer was then inserted in pS_XRKR by Golden
Gate cloning using the BsaI enzyme (NEB). Ligation and digestion were
performed concomitantly for 1 h at 37 °C.
2.4. Selection of mutant strains
C. beijerinckii NCIMB 8052 recombinant strains harboring the two
plasmids of the CRISPR-Cas9 system were grown at 37 °C in 25mL li-
quid mCGM medium containing 0 (without induction) or 40 g/L xylose
(pre-induction) for 24 h–3 days to induce the CRISPR-Cas9 system.
Once the optical density of the culture containing xylose reached
1.5 mAU at 600 nm, these cultures were concentrated in 100 µL of fresh
mCGM media. 50 µL of the cell suspension were spread on mCGM se-
lective plates supplemented 40 g/L xylose, 50 µg/mL erythromycin and
650 µg/mL spectinomycin and incubated for 24 h–3 days to obtain
single colonies. Edited cells were screened by colony PCR to detect
single and double allelic exchange proﬁles.
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C. beijerinckii DSM 6423 recombinant colonies bearing a single- or
dual-plasmid genome editing system were treated as described pre-
viously [30], with a 200 ng/mL anhydrotetracycline (Sigma-Aldrich)
induction.
2.5. Fermentation assays
Fermentations were performed in CM2 medium [41] which contains
per liter: yeast extract, 5 g; KH2PO4, 1 g; K2HPO4, 0.76 g; NH4Ac, 3 g; p-
aminobenzoic acid, 0.1 g; MgSO4·7 H2O, 1 g; and FeSO4·7 H2O, 0.5 g,
glucose, 60 g. 50mL of media were inoculated with 250 µL of a heat
shocked fresh spore suspension and incubated overnight at 35 °C. The
overnight cultures were inoculated (5% (v/v)) in fresh culture medium
and incubated at 35 °C for 72 h. The concentrations of metabolites were
determined in clear culture supernatants after removal of microbial
biomass by centrifugation. Glucose, acetate, butyrate, lactate, acetoin,
acetone, butanol and ethanol were determined by HPLC as described
previously [2,42] using valeric acid (30mM) as an internal standard.
2.6. Microscopy
Phase contrast microscopy (Olympus BX51; Olympus, Tokyo,
Japan) was used to determine the presence of endospores or pre-spore
stages. Native bacteria were observed by phase contrast microscopy at
×1000 magniﬁcations.
3. Results
3.1. Genome editing strategy
The cas9 gene was placed on a diﬀerent plasmid from the gRNA
expression cassette and the editing template so that (1) cloning was
facilitated (i.e. with the use of smaller plasmids) and (2) space was
available for large editing templates. Since previous CRISPR-Cas9-re-
lated studies in Clostridia hypothesized that DSBs catalyzed by Cas9 are
likely to severely impair transformation eﬃciency [22,43], both the
cas9 gene located on pE_X_cas9 and the gRNA expression cassette lo-
cated on pS_XKR were placed under the control of the inducible pro-
moter PxylB from C. diﬃcile str. 630 [32] (Supplementary ﬁle S2). To
complete our 2-plasmid inducible system, the xylR regulatory gene was
further cloned into the plasmid pS_XKR yielding pS_XRKR.
Editing templates and gRNA expression cassettes were thus inserted
into the pS_XRKR plasmid (Fig. 1a). Each editing template contains two
homology sequences (HS) of at least 500 bp, named HS1 and HS2. For
genomic deletion, the two HS ﬂank the region that has to be removed,
which contains the CRISPR target site. Genomic insertions were de-
signed by placing the sequence of interest between HS1 and HS2. This
conﬁguration allows 3 diﬀerent allelic exchange events between the
genome and the plasmid containing the DNA template (Supplementary
ﬁle S3): two single-crossover allelic exchanges (SAE) and one double-
crossover allelic exchange (DAE). The latter exchange is the only one
which results in genomic DNA without the CRISPR-Cas9 target, which
enables the survival of the transformants upon Cas9 induction.
The pS_XRKR-based targeting plasmids were then introduced into a
C. beijerinckii NCIMB 8052 recombinant strain already transformed with
the pE_X_cas9 plasmid (Fig. 1b–c).
Following plasmid selection, xylose was used to induce the ex-
pression of both cas9 and the gRNA. This critical step enables the se-
lection of correctly edited cells, as, in the absence of non-homologous
repair systems, Cas9 targets the bacterial chromosome, resulting in cell
death. The ﬁnal recombinant strains were next obtained by curing the
pS_XRKR-based plasmid and the pE_X_cas9 plasmid by serial sub-
culturing in mCGM media lacking both antibiotics (Fig. 1d–e). Alter-
natively, selectively curing the targeting plasmid allows to directly
reuse the modiﬁed cells for another round of genome editing (Fig. 1g).
To evaluate the robustness of this new genome-editing approach for
Fig. 1. Dual-plasmid inducible CRISPR-Cas9 strategy for C. beijerinckii NCIMB
8052 genome editing. a. Preliminary cloning of homology sequences and gRNA
protospacer in pS_XRKR plasmid to obtain a targeting plasmid. b,c.
Transformation of (b) pE_X_cas9 in the WT strain and (c) of the targeting
plasmid in the latter strain. d. Induction of cas9 and gRNA expression to yield
an edited strain. e,f,g. Curing of the targeting plasmid (e) and pE_X_cas9
plasmid (f) yields a markerless genome edited mutant. Alternatively (g), the
targeting plasmid can be speciﬁcally removed to promote another round of
genome editing. gRNA: guide RNA; EmR: erythromycin resistance marker; SmR:
spectinomycin resistance marker.
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modiﬁcation of C. beijerinckii NCIIMB 8052, the system was used for: (i)
a gene deletion and (ii) a gene insertion. The modiﬁcations performed
in this study and their characteristics are summarized in Table 2.
3.2. Deletion of the spoIIE gene, characterization of the edited strains and
complementation with a functional spoIIE gene
The spoIIE gene (cbei_0097) encoding a phosphatase involved in the
sporulation regulation was targeted ﬁrst. In model organisms Bacillus
subtilis and C. acetobutylicum, SpoIIE is involved in the ﬁrst steps (Stage
II) of the regulation the sporulation mechanisms cycle [44,45]. It en-
ables the activation of the sporulation-speciﬁc sigma factor σF and is
necessary to complete asymmetric division. In C. acetobutylicum, SpoIIE
inactivation does not impair solvent production [46,47]. The
pS_XΔspoIIE_S1 plasmid contains the “ΔspoIIE” DNA editing template
(Table 1 and Fig. 2a) and the “spoIIE_S1” gRNA. HS1 and HS2 templates
were designed to remove 2379 bp within the coding sequence of the
spoIIE gene. Without induction of the CRISPR-Cas9 machinery, PCR
screening showed that the full pS_XΔspoIIE_S1 plasmid frequently in-
tegrated into the host genome by SAE mechanisms either with HS1 or
with HS2. However, no DAE event was observed (data not shown).
Overnight xylose induction in the C. beijerinckii (pE_X_cas9,
pS_XΔspoIIE_S1) strain negatively aﬀected its growth, suggesting a toxic
eﬀect of Cas9 activity (Fig. 2c). This overnight culture was then plated
on mCGM agar containing xylose (Fig. 2d), which permitted the se-
lection of correctly edited ΔspoIIE cells (7/7 DAE events, Fig. 2e and
Table 2). Microscopic analysis showed that the ΔspoIIE cells were more
elongated than the wild-type cells and did not form viable endospores
(Fig. 3a-b). Similarly to what was observed in C. acetobutylicum, mutant
strains were still able to produce solvents (Supplementary ﬁle S4). To
test whether the asporogeneous phenotype was eﬀectively caused by
the disruption of the spoIIE gene, complementation with a plasmidic
copy of the spoIIE gene under the control of its native promoter was
performed. As expected, sporulation was restored in the complemented
mutant (Fig. 3a-b).
3.3. Insertion of the celA gene from Neocallimastix patriciarum
The celA gene from the fungus Neocallimatix patriciarum [48,49],
encoding a cellobiohydrolase, was inserted downstream of the hbd gene
(cbei_0325). The pS_XR_celA_S1 plasmid, harboring the “celA” DNA
template (Table 1 and Fig. 2b) and the “celA_S1” gRNA, was introduced
in strain NCIMB 8052 (pE_X_cas9). The celA template was designed to
enable the insertion of the celA gene under the control of the thiolase
promoter from C. beijerinckii (1667 bp) and the deletion of a 19 bp se-
quence located 36 base pairs downstream of the stop codon of the hbd
gene (cbei_0325).
Similarly to what was observed for spoIIE inactivation, only SAE
events were detected by PCR in the transformants containing pE_X_cas9
and pS_XR_celA_S1, prior to xylose induction. Following xylose induc-
tion, 3 out of the 4 xylose-resistant colonies tested were correctly edited
(Fig. 2e and Table 2).
The resulting celA mutants displayed cellulolytic activity on mCGM
plates containing 1 g/L CMC (carboxymethylcellulose), similarly to a
control C. beijerinckii strain carrying the celA transcription unit on a
plasmid (pWUR3, [48]) (Fig. 3b).
3.4. Adaptation of the dual-plasmid genome editing strategy to C.
beijerinckii DSM 6423
The advantages provided by a two-plasmid CRISPR-Cas9 genome
editing system (i.e. scarless modiﬁcations, high eﬃciency, relatively
high DNA cargo capacity) prompted us to develop a similar system in
the poorly studied C. beijerinckii DSM 6423 strain. A ﬁrst obstacle was
the lack of knowledge on the transformability of this natural IBE pro-
ducer. This hurdle was overcome by applying a DNA demethylation
strategy prior to electroporation, as described by Kolek et al. [33] in the
closely related C. beijerinckii NRRL B-598 strain (Supplementary ﬁle
S7). This treatment enabled the generation of transformants containing
pFW01-derived vectors [30,50] (Supplementary ﬁle 7). However, vec-
tors bearing the spectinomycin resistance marker could not be in-
troduced successfully in this strain (data not shown). This was a major
bottleneck for the use of a two-plasmid editing strategy since this mi-
croorganism was also resistant to thiamphenicol, an antibiotic often
used for selection in clostridial recombinant systems [51].
To alleviate this second obstacle, a single-plasmid CRISPR-based
approach was developed to disrupt the catB gene (CIBE_3859), pre-
dicted to encode an amphenicol acetyltransferase probably involved in
thiamphenicol resistance. pE_X_cas9 plasmid was not chosen as a
backbone since this already large vector (≈13 kb, Supplementary ﬁle
S2) does not carry the xylR gene necessary for cas9 inducibility. Instead,
the 8874 bp pCas9ind plasmid previously used for genome editing in C.
acetobutylicum ATCC 824 [30] was engineered to include an anhy-
drotetracycline-inducible gRNA expression cassette targeting catB as
well as homology sequences designed to delete 99% of the catB gene
(Fig. 4a, Table 2). The resulting pCas9ind-ΔcatB_S1 vector was in-
troduced in C. beijerinckii DSM 6423, and mutants with the expected
catB deletion were obtained after anhydrotetracycline (aTc) induction
(Fig. 4b).
As anticipated, these ΔcatB mutants were sensitive to thiamphenicol
(Fig. 4c) and allowed the maintenance of the pEC750C vector in this
modiﬁed strain, which carries the catP marker from C. perfringens [52].
Besides, this vector could be introduced in a strain already bearing a
pFW01-based plasmid. In order to test whether a dual-plasmid CRISPR-
Cas9 editing approach could be applied to the ΔcatB mutant, we con-
structed a pEC750C-based plasmid carrying an aTc-inducible gRNA
cassette targeting the endogenous pNF2 plasmid (pGRNA-pNF2_S1).
The pNF2 plasmid [53] was discovered during the reconstruction of C.
beijerinckii DSM 6423 genome along with other extra-chromosomic
genetic elements (i.e. another plasmid and a linear phage). The pNF2
plasmid is the smallest of these elements (4282 bp) and bears 4 putative
genes, 3 of which have no predicted function, and the last one is pre-
dicted to encode a potential plasmid replication protein. The pGRNA-
pNF2_S1 vector was subsequently introduced in C. beijerinckii DSM
6423 ΔcatB (pCas9ind) which allowed the highly eﬃcient selection of
ΔpNF2 mutants (Fig. 4d–e). Fermentation assays further revealed that
the deletion of ΔpNF2 did not aﬀect alcohol production (Supplementary
ﬁle S8). However, pNF2 removal resulted in increased transformation
Table 2
Chromosomic modiﬁcations performed in this study.
Strain DNA template Size of the sequences (base pairs) Screening resultsa
Deleted Inserted HS1 HS2 DAE WT DAE & WT “-”
NCIMB 8052 ΔspoIIE 2424 0 741 1020 7 0 0 1
celA 19 1667 1001 1017 4 0 0 1
DSM 6423 ΔcatB 653 8 400 400 3 0 0 1
HS1 and HS2 Homologous sequence; WT: wild type; DAE: Double allelic exchange; SAE: Single allelic exchange; “-”: no ampliﬁcation.
a Screening was performed on colonies growing with the highest xylose/aTc concentrations.
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eﬃciencies (from 20 to 2000 fold depending on the plasmid, Fig. 4f).
In summary, we successfully adapted the two-plasmid CRISPR-Cas9
editing tool to C. beijerinckii DSM 6423 and created successively two
platform strains. The ﬁrst modiﬁcation made the strain sensitive to
thiamphenicol, which allowed us to use two diﬀerent resistance mar-
kers. This mutant strain was further engineered by removing pNF2
which allowed us to obtain a second strain, with higher transformation
eﬃciencies.
4. Discussion
In this study we describe the successful adaptation of a CRISPR/
Cas9 genetic tool in the solvent-producing C. beijerinckii. The two-
plasmid system, in which the cas9 gene was cloned on a ﬁrst plasmid -
the nuclease plasmid - while the gRNA and the DNA template were
cloned on a second plasmid – the editing plasmid, was successfully used
to edit the genome of two reference strains of C. beijerinckii. Such a
method beneﬁts its user on several points. Firstly, the cloning procedure
is facilitated because the toxic genes of the CRISPR-Cas9 machinery are
localized on separate genetic elements. Therefore, it is easier to con-
struct plasmids for a given genetic modiﬁcation, which will also be
signiﬁcantly smaller, likely resulting in higher transformation eﬃ-
ciencies in Clostridia.
Secondly, our methodology helps reducing the time spent on the
traditionally laborious genetic engineering steps. The strain bearing the
nuclease plasmid can indeed be stored at −80 °C and used multiple
Fig. 2. Genome editing of the C. beijerinckii
NCIMB 8052 strain: design and selection. a,
b. Targeted loci and their relative DNA
templates. (a) Disruption of spoIIE. (b)
Insertion of the celA gene from N. patri-
ciarum. c, d, e. Selection and screening of
edited strain. (c) Growth of C. beijerinckii
NCIMB 8052 pE_X_cas9 transformed with
the empty gRNA plasmid pS_XRKR or the
spoIIE disruption plasmid pS_XΔspoIIE_S1.
The transformants were grown in duplicates
in mCGM supplemented with erythromycin
and spectinomycin and with 0–4% of xylose.
The error bars represent the error of the
replicates (d) Selection of spoIIE on mCGM
agar plate containing 0 or 4% xylose (w/v)
inoculated with overnight pre-induced cul-
tures. (e) Growing xylose-resistant colonies
were subsequently screened by colony PCR.
The screening for spoIIE gene disruption was
performed using primers cbei_0096_F/
cbei_0098_R. Expected sizes: 5462 bp (WT)
and 3083 bp (DAE). The screening of the
insertion of the celA gene was performed
using primers cbei_0325_F/cbei_0326_R.
Expected sizes: 2083 bp (WT) and 3607 bp
(DAE). HS1 and HS2: homologous sequence
1 and 2; SP_eglA: signal peptide eglA; pthl:
promoter of C. beijerinckii thiolase gene
(cbei_3630); WT: wild type; DAE: double
allelic exchange (edited cells).
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times, for several genetic constructions. Similarly, the editing plasmid
can be speciﬁcally cured after a genome editing experiment, permitting
multiple successive rounds of genome editing. This editing plasmid was
besides designed to fasten the cloning process by incorporating genetic
elements allowing a quick and easy reprogramming of the gRNA. In our
hands, CRISPR-Cas9-based counter-selection also proved to be ex-
tremely eﬃcient with most clones – if not all – edited after the induc-
tion step, which also contributes to shorten the mutant screening pro-
cess.
Lastly, the system displays a good genetic cargo capacity (up to
3.5 kb insertions with C. acetobutylicum [30]), which makes it suited for
large genome modiﬁcations required for metabolic engineering. The
additional space provided by the second plasmid also gives more
freedom for the design of DNA templates and notably enables the use of
longer homologous sequence to favor allelic exchanges [54].
In the CRISPR system described in this study, an inducible Cas9
nuclease [24,31] was chosen over the Cas9 nickase previously used by
other groups [22,23]. In those studies, edited cells were obtained at
lower frequencies than in studies when the Cas9 nuclease was used.
This can be explained by a lower toxicity of a single nick in the genome,
rather than a DSB. Since the Cas9 nickase is less toxic, and therefore less
selective, its use increases the probability of having a mixed population,
especially when the desired mutation negatively impacts the ﬁtness of
the bacterium, or when the editing events are rare (e.g. insertion of
large DNA fragments). As an example, the disruption of adc in C.
acetobutylicum or C. beijerinckii using the nickase led to the isolation of 1
and 3 correctly edited colonies out of 16 colonies tested, respectively,
whereas other mutations (xylR, cbei_3923) were obtained in almost all
of the tested colonies [23].
In order to use Cas9, the inducible promoter PxylB from C. diﬃcile
and the xylR gene, whose product codes for the associated regulatory
protein [32], were used to control the expression of both cas9 and the
gRNA. The lethal eﬀect of the DSB resulting from their expression fol-
lowing xylose induction was then used as a strong counter selection
marker. In this study, this approach allowed the isolation of correctly
edited cells at an eﬃciency close to 100%. Moreover, unlike what is
reported in studies using the Cas9 nickase, serial transfers of re-
combinant strains were not required to isolate clones that undergone
large fragment insertions in their genome. All mutants generated in this
study were therefore isolated within one week starting from the strain
C. beijerinckii NCIMB 8052 (pE_X_cas9). Although the system is medi-
ated by two plasmids, their removal required only a few serial transfers
making the system as eﬃcient as those previously described. The easy
clearance of the plasmids carrying the gRNA and DNA template and the
absence of selection marker in the ﬁnal strain thus enable multiple
rounds of genome editing.
In this study, we deleted a 2.379 kb DNA fragment within the spoIIE
gene (cbei_0097), and inserted the 1.68 kbN. patriciarum celA gene. The
disruption of the spoIIE gene, described here for the ﬁrst time in C.
beijerinckii, resulted in asporogenous mutant strains. These results are in
accordance with studies in earlier Bacillus subtilis [55] and other sol-
ventogenic Clostridia [46,56], which showed that a reduced spoIIE ex-
pression coincided with hampered sporulation and that spoIIE disrup-
tion prevents sporulation.
The spoIIE mutants generated in this study kept the ability to pro-
duce solvents at similar levels to the wild-type strain (Supplementary
ﬁle S4). These observations indicate that this gene is necessary for
sporulation but does not play a role in solvent production, contrary to
spo0A for example. This characteristic has also been observed in spoIIE
negative mutants generated in C. acetobutylicum [46,47]. In contrast to
the spo0A homologues in Clostridia, the spoIIE gene is not well con-
served between clostridial species. Indeed, while C. acetobutylicum
Fig. 3. Novel phenotypes in genetically modiﬁed C. beijerinckii NCIMB 8052 mutants. a. Light microscopy pictures at 73 h of fermentation of C. beijerinckii NCIMB
8052wt, ΔspoIIE, CMspoIIE (complemented mutant) strains. Spores are marked by a triangle. b. Growth of C. beijerinckii NCIMB 8052wt, ΔspoIIE, CMspoIIE on CM2
agar plates after heat shocking 200 µL of a 48-hour-old culture. c. Detection of the cellulase activity of C. beijerinckii celA mutants. WT: C. beijerinckii wild type, 2–5:
clone number (CelA mutants after plasmid curing), +: positive control (non-integrated self-replicating CelA plasmid) the halo surrounding the cells are caused by the
degradation of carboxymethylcellulose.
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Fig. 4. Adaptation of the two-plasmid CRISPR-Cas9 system to C. beijerinckii DSM 6423. a. catB (CIBE_3859) genome deletion design by a single-plasmid strategy. b.
Veriﬁcation of catB deletion by PCR with primers RH76 and RH77, which amplify a genome region encompassing the homology sequences (expected sizes: 1553
(WT) and 900 (ΔcatB) bp). c. Thiamphenicol resistance assay on the resulting ΔcatB strain. d. Map of the natural pNF2 plasmid from C. beijerinckii DSM 6423. The
locus targeted by the pGRNA-pNF2_S1 vector (containing the thiamphenicol resistance gene catP) is shown in red. e. Veriﬁcation of the deletion of the pNF2 plasmid
with a dual-plasmid CRISPR-Cas9 strategy. Primers pNF2_fwd and pNF2_rev were used for PCR (expected size: 907 bp (WT); no ampliﬁcation is expected from a
ΔcatBΔpNF2 strain). f. Transformation eﬃciencies in the wild-type, the ΔcatB and the ΔcatB ΔpNF2 strain. Errors bars represent the s.e.m. of duplicate experiments.
EmR: erythromycin resistance gene TmR: thiamphenicol resistance gene. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the
web version of this article.)
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spoIIE gene has only 36% identity with C. beijerinckii spoIIE, spo0A
homologues have as much as 74% sequence identity. We observed
diﬀerences at the phenotypic level between C. acetobutylicum and C.
beijerinckii spoIIE mutants. Indeed spoIIE mutants in C. beijerinckii have
two dark spots at their poles (Fig. 3), corresponding to the forespore
condensed DNA, that are absent in C. acetobutylicum spoIIE mutants but
were observed in C. acetobutylicum sigE mutants [57]. Moreover C.
beijerinckii spoIIE mutant cells display an asymmetric septum and
sometimes two septa at each pole of the cell, which is similar to the
morphology of B. subtilis spoIIE mutants [44,58]. We can thus hy-
pothesize that even though SpoIIE is necessary for the correct com-
pletion of the stage II of the sporulation cycle in C. beijerinckii and C.
acetobutylicum, it is not needed for asymmetric septum formation in C.
beijerinckii in contrary to what is observed in C. acetobutylicum.
The insertion of the “thlp_celA” transcriptional unit yielded mutant
strains which showed cellulase activity on plate assays, not observed
with the WT strain. The CelA enzyme from the anaerobic fungus N.
patriciarum is a cellulase that contains an active domain belonging to
the Family 6 of glycosyl hydrolases. This enzyme has been expressed
before in clostridial strains using a plasmid vector, either alone or as
part of a mini-cellulosome [48,59]. This study shows for the ﬁrst time
the insertion of a cellulase gene into the chromosome of a solventogenic
strain and its functional expression. This opens novel possibilities for
the direct fermentation of sugar polymers like cellulose into ABE or IBE
mixtures.
The success of our genome editing strategy prompted us to apply it
also to another strain. The atypical C. beijerinckii DSM 6423 is geneti-
cally very close to the NCIMB 8052 model strain [60], but its mod-
iﬁcation by targeted genome editing techniques has however never
been reported, in spite of the microorganism value as being one of the
few natural IBE-producing strains. Taking into account this strain
characteristics, we successfully adapted our dual-plasmid inducible
CRISPR-Cas9 approach. Indeed, some adjustments were found neces-
sary to (1) circumvent the restriction-modiﬁcation system of the strain
(using Dam− Dcm− DNA, similarly to the NRRL B-598 strain [33]) and
(2) ﬁnd an alternative to the spectinomycin resistance gene, which
proved to be malfunctioning in our hands. This bottleneck was speci-
ﬁcally tackled by using a single-plasmid inducible CRISPR-Cas9
strategy to disrupt a putative amphenicol resistance gene (CIBE_3859,
encoding the catB gene). The resulting strain was demonstrated to be
sensitive to thiamphenicol, and the catP resistance marker (from C.
perfringens [52], used extensively in C. acetobutylicum [51]) could sub-
sequently be used in this mutant. This mutant was further exploited to
delete the pNF2 natural plasmid [53] with a dual-plasmid inducible
CRISPR-Cas9 system, underlining the compatibility of the ΔcatB strain
with such a system. The curation of the pNF2 plasmid was preferred to
the modiﬁcation of chromosomal genes because it required the in-
troduction of a small editing plasmid without editing template. Indeed
the poor transformation eﬃciency of the DSM 6423 strain severely
impedes our eﬀorts. For the disruption of the catB gene for example,
several transformation experiments were required to introduce the
single-plasmid inducible CRISPR-Cas9 and only one was successful,
yielding 1 transformant when using 20 µg DNA. This problem under-
lines the need for better transformation eﬃciencies in C. beijerinckii
DSM 6423 for future genome editing experiments.
CRISPR-Cas9-based removal of non-essential genetic elements has
already been pioneered in solventogenic Clostridia, with notable eﬀects
on the primary/secondary metabolism and/or on exogenous plasmid
transformation eﬃciencies [30,61]. If the product pattern and quan-
tities of the resulting ΔcatB ΔpNF2 strain were not strongly aﬀected, the
mutant interestingly showed much higher transformation eﬃciencies,
most likely because the endogenous pNF2 plasmid interferes with the
replication of non-natural plasmids introduced into the cell. As men-
tioned above, this improvement is critical as transformation eﬃciencies
are normally extremely low in the wild-type genetic background (c.a.
4 CFU/µg with an empty plasmid – Supplementary ﬁle S7), which will
likely considerably help constructing future strains. The rise of the
CRISPR/Cas9 technology in the ﬁeld of Clostridium genetics has been a
real breakthrough. The relatively simple generation of scarless mutants
in a short period of time will hopefully facilitate the research into the
physiology of solvent production and lead to a better understanding of
the regulatory mechanisms involved in gene expression. The dual-
plasmid system described in this study should overcome issues reported
previously (higher transformation eﬃciency, ﬂexibility for the design of
DNA templates, convenience of the cloning procedure, rapid mutant
selection, cargo capacity). We showed here that this advantageous
system, initially developed for C. acetobutylicum, could be simply
adapted to work as eﬃciently in a model microorganism from another
species. We also demonstrated that this approach could be expanded to
atypical microorganisms, recalcitrant to genetic manipulations, by fol-
lowing simple steps (i.e. ﬁnding the correct DNA methylation pattern,
removing antibiotic resistance genes, removing mobile genetic ele-
ments), which suggests that similar strategies are likely to function in
other prokaryotes.
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